Missed a story over the past week? Catch up with our weekly update:
News for the week of 13 – 19 Jan 2014:
University of Arizona develops test to identify early mortality syndrome in shrimp.
Life sciences firm Promentis Pharmaceuticals raises $2.9m to develop drugs targeting schizophrenia and other central nervous system disorders.
Oncology accelerator lands on MaRS
MaRS Innovation partners on Triphase oncology development accelerator.
University of New Brunswick spin-out Smart Skin banks $3.9m from a number of backers for artificial touch-sensitive film.
Learning content management platform Blackboard acquires academic information platform MyEdu.
Arizona State University receives $1m grant from the US Department of Defence to create new tech transfer centre.
Horizon Discovery, a life science spin-out of Cambridge University, signs its second collaboration with pharmaceutical firm AstraZeneca.
Researchers from three Scottish universities suggest UK Government is over-subsidising tech firms which cannot grow.
Life sciences firm NanoVision Diagnostics, spun out from the University of Pittsburgh last year, raises $1.5m for early stage cancer detection.
Dundee University receives £2m ($3.28m) to develop centre for marine renewable future.
Madison Vaccines, a life sciences firm developing therapies for prostate cancer, closes $8m series A.
Already launching in December with one of the largest series A rounds in history, Juno Therapeutics extends the venture round by a further $25m.
University of Washington spin-out SNUPI Technologies has raised $7.5m in series A for a device to look for water leaks.
The University of Texas Health Science Centre at San Antonio scouts for new executive director at its Office of Technology Transfer after Arjun Sanga departs for Wisconsin.
Rocket Ventures severs ties with the University of Toledo to extend focus across the northwest Ohio region.
